Daniel Fuster

Associate Professor

University of Barcelona

Spain

Research Interests

Explore related searches

Professors in Spain

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Daniel Fuster is an Associate Professor at Universitat de Barcelona, Spain. His research primarily focuses on the interactions between substance use disorders and liver health, with recent articles examining topics such as the association between cigarette smoking and liver fibrosis in HIV-positive individuals, the clinical features of alcohol use disorder, and the implications of vitamin D deficiency in those conditions. He also explores the immune response in patients with lung cancer and the abuse potential of various substances.

Articles (15)

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Collaborators (6)

Magi Farre

Head of Department

Hospital Universitari Germans Trias i Pujol

SPAIN

View details

Marta Torrens

Parc de Salut

SPAIN

View details

Joseph Studer

Lausanne University Hospital

SWITZERLAND

View details

Ainhoa Hernandez

Catalan Institute of Oncology

SPAIN

View details

Cristina Llorente

Assistant Adjunct Professor

UC San Diego Health System

UNITED STATES

View details

Eva Martínez-Cáceres

Associate Professor Immunology

University of Barcelona

SPAIN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Daniel Fuster

Research Interests

Explore related searches

Contact this professor

About

Articles (15)

Is There an Association Between Cigarette Smoking and Advanced Liver Fibrosis in Smokers with HIV, Heavy Drinking and High Prevalence of HCV?

Clinical features of individuals with laboratory values suggestive of advanced liver fibrosis when first treated for alcohol use disorder

Trastorno por uso de sustancias: epidemiología, complicaciones médicas y tratamiento

Vitamin D Deficiency Is Associated with Advanced Liver Fibrosis and Impaired Fasting Glucose in Alcohol Use Disorder

Treatment of alcohol use disorder in patients with alcohol-associated liver disease: Innovative approaches and a call to action

Fungal plasma biomarkers in patients admitted for inpatient treatment of alcohol use disorder

Abuse Potential of Cathinones in Humans: A Systematic Review

Immune Response and Effects of COVID-19 Vaccination in Patients with Lung Cancer-COVID Lung Vaccine Study

Increased Natural Killer Cells Are Associated with Alcohol Liver Fibrosis and with T Cell and Cytotoxic Subpopulations Change

Correlates of the use of electronic devices to vape cannabis in a cohort of young Swiss male reporting current cannabis use

Lack of Association Between Recent Cannabis Use and Advanced Liver Fibrosis Among HIV-positive Heavy Drinkers

Markers of Monocyte Activation, Inflammation, and Microbial Translocation Are Associated with Liver Fibrosis in Alcohol Use Disorder

Alcohol Consumption and Hepatitis C Virus (HCV) RNA Levels in HIV/HCV Coinfected Patients

Utilización de opioides para el dolor crónico no oncológico. Respuesta

Cannabis use is associated with monocyte activation (sCD163) in patients admitted for alcohol use disorder treatment

Collaborators (6)

Magi Farre

Marta Torrens

Joseph Studer

Ainhoa Hernandez

Cristina Llorente

Eva Martínez-Cáceres

Make your next move.